MI HR0181

Resolution urges the U.S. Food and Drug Administration to address current shortages of critical, lifesaving drugs.

Documents significant increases in drug shortages, with 186 new shortages in 2018 (27% increase from 2017) and 282 drugs in active shortage in the first half of 2019.

Identifies specific drugs affected by shortages, including intravenous immunoglobulin (IVIG), intravenous sodium bicarbonate, and EpiPen injections.

Highlights that drug shortages force healthcare providers to ration drugs, prioritize patients, and result in adverse events including mortality, treatment changes, and medication errors.

Notes that drug shortages cost hospitals and health facilities at least $359 million per year in labor costs and increase patient out-of-pocket expenses.